Virpax Pharmaceuticals, Inc.
VRPXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Jul 10, 2024; 12 institutions reported holding it in 13F filings for Q4 2024, worth $46.7K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 12
- Q4 2024, +3 vs. previous quarter
- 13F value
- $46.7K
- Reported value at the end of Q4 2024
- Superinvestors holding
- 0
- At the end of Q4 2024
Superinvestors holding VRPX, Q4 2024
No superinvestor reported holding VRPX at the end of Q4 2024.
Latest insider trades
Open-market purchases and sales by Virpax Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2022 (view filing) | May 24 | 2 days | Sendrow JerroldDirector | PPurchaseCommon Stock, $0.00001 par value | +4.50K | $1.29 | +$5.80K | +99.9%9.01K after | |
| May 20, 2022 (view filing) | May 18 | 2 days | Mack Anthony P.Chief Executive Officer | PPurchaseCommon Stock, $0.00001 par value | +75.8K | $1.34 | +$101.5K | +42.8%252.6K after | |
| May 20, 2022 (view filing) | May 18 | 2 days | Floyd EricDirector | PPurchaseCommon Stock, $0.00001 par value | +4.48K | $1.36 | +$6.09K | +126.6%8.02K after | |
| Nov 24, 2021 (view filing) | Nov 22 | 2 days | Sendrow JerroldDirector | PPurchaseCommon Stock, $0.00001 par value | +3.90K | $3.93 | +$15.3K | +643.6%4.51K after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Mack Anthony P.Chief Executive Officer | PPurchaseCommon Stock, $0.00001 par value | +25.1K | $3.99 | +$100.2K | +16.6%176.8K after |
Top 10 13F holders, Q4 2024
The largest institutional positions in Virpax Pharmaceuticals, Inc. at the end of Q4 2024; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 41,899 | $15.5K | 0.00% | +13,928+49.8% | Added |
| HRT Financial LP | 25,368 | $9.00K | 0.00% | +25,368 | New |
| Virtu Financial LLC | 23,657 | $9.00K | 0.00% | +23,657 | New |
| UBS Group AG | 13,100 | $4.98K | 0.00% | −7,335−35.9% | Reduced |
| XTX Topco Ltd | 12,905 | $4.77K | 0.00% | +12,905 | New |
| Tower Research Capital LLC (TRC) | 7,754 | $2.95K | 0.00% | +3,917+102.1% | Added |
| SBI Securities Co., Ltd. | 600 | $228 | 0.00% | +600 | New |
| Morgan Stanley | 499 | $190 | 0.00% | +484+3,226.7% | Added |
| Advisor Group Holdings, Inc. | 240 | $91 | 0.00% | +240 | New |
| Vermillion Wealth Management, Inc. | 100 | $38 | 0.00% | +100 | New |